Lazard Asset Management’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4	Closed	-$3K	–	2540
2023 Q3	$3K	Hold	4	–	–	﹤0.01%	2194
2023 Q2	$19K	Buy	+4	New	+$19K	﹤0.01%	2111